Partnership Opportunities
Our goal is to create partnerships with companies to help minimize their investment risk by providing the research environment, expertise, clinical samples and joint funding to conduct the preclinical and early-stage clinical research necessary to find treatments that would otherwise be ignored in the traditional for-profit, drug-development process. We see this as a revolutionary business model that will accelerate access to treatment for pediatric patients.
Potential partnerships are available in these areas:
Therapeutics
- ADHD
- Allergy and Asthma – Mast Cells
- Asthma and Lung Inflammation
- Autoimmunity and Cancer
- Autoimmunity and Primary Immunodeficiency
- Autoimmunity – High-Specificity Targets
- Bone Disorders and Malformations
- Brain Malformations
- Cancer – Cadherin-Mediated Interventions
- Cancer – Immunotherapy
- Cancer – Neuroblastoma
- Cancer – Neurotoxicity
- Cerebellar Development
- Chronic Pain
- Concussion
- Congenital Disorders of Glycosylation
- Craniofacial Malformations – Clinical Data
- Duchenne Muscular Dystrophy – Zebrafish Models
- Epilepsy – Stem Cell Models
- Fibrosis
- Heart Arrhythmia
- Heart Metabolism and Function
- Heart Surgery – “Ductal Paint”
- Heart Transplant – Eplet Mismatches
- Heart Transplant – Extracorporeal Photophoresis
- Heart Transplant – Immunoreactivity and Tolerance
- Hemoglobinopathies
- Hemophilia – Immunomodulation Therapy
- Hemophilia – Intraosseous Lentiviral Therapy
- HIV – CAR-T therapies
- HIV Microbiomes
- HIV – Viral Reservoirs
- Human Papillomavirus
- Hypoplastic Left Heart Syndrome
- Infantile Hemangiomas and Other Vascular Malformations
- Inflammatory Bowel Disease--Cadherin-Mediated Interventions
- Inflammatory Bowel Disease--Dietary Modifications
- Juvenile Idiopathic Arthritis (JIA) and Juvenile Dermatomyositis (JDM) – Microbiome
- Kawasaki Disease
- Lupus - B-Cell Targets
- Lupus – T-Cell Targets
- Lymphatic Malformations
- Motor Impairments and Paralysis
- Next-Generation Newborn Screening to Improve Treatment Efficacy
- Obesity
- Pain
- Retinal Disorders
- Wilson Disease and Other Lysosomal Storage Diseases--Newborn Screening
Diagnostics
- Autism – Characterizing Protein Interactions
- Cancer – Neuroblastoma
- Cancer – Neurotoxicity
- Concussion
- Healthcare Associated Infections
- Heart Transplant – Eplet Mismatches
- Heart Transplant – Immunoreactivity and Tolerance
- HIV – Viral Reservoirs
- Human Herpesvirus HHV-6 – Epidemiology
- Human Papillomavirus
- Immune Dysregulation Syndromes
- Infantile Hemangiomas and Other Vascular Malformations
- Kawasaki Disease
- Lupus - B-Cell Targets
- Metabolic Disorders – Newborn Screening
- Mosaic Mutations
- Retinal Disorders
- Scleroderma
- Sepsis
- Sleep Apnea
Medical Devices
- Activity Trackers and Apps
- Craniofacial Malformations – Clinical Data
- Epilepsy – Medical Device Interventions
- Heart Arrhythmia
- Hemophilia – Gene Therapy
- Hypoplastic Left Heart Syndrome
- Motor Impairments and Paralysis
- Sleep Apnea
Vaccines
Research Tools and Understanding Disease Pathways
- Addiction – Characterizing Pathways
- Allergy and Asthma – Mast Cells
- Anesthesia Risks
- Autism – Characterizing Protein Interactions
- Autoimmunity and Cancer
- Autoimmunity and Primary Immunodeficiency
- Autoimmunity – High-Specificity Targets
- Asthma
- Asthma and Lung Inflammation
- Bone Disorders and Malformations
- Brain Overgrowth Diseases
- Brain Malformations
- Breathing Dysregulation
- Cancer – Cadherin-Mediated Interventions
- Cancer – Immunotherapy
- Cancer – Neuroblastoma
- Cancer – Neurotoxicity
- Cerebellar Development
- Congenital Disorders of Glycosylation
- Craniofacial Birth Defects
- Dravet Syndrome – Advanced Animal Model
- Duchenne Muscular Dystrophy – Zebrafish Models
- Epilepsy – Stem Cell Models
- Fibrosis
- Food Insecurity and Chronic Disease Management
- Healthcare Associated Infections
- Heart Metabolism and Function
- Heart Surgery – “Ductal Paint”
- Heart Transplant – Eplet Mismatches
- Heart Transplant – Extracorporeal Photophoresis
- Heart Transplant – Immunoreactivity and Tolerance
- Hemoglobinopathies
- HIV Microbiomes
- HIV Tissue Reservoirs
- HIV – Viral Reservoirs
- Human Herpesvirus HHV-6 – Epidemiology
- Human Herpesvirus HHV-6 and HHV-7 Infections
- Human Papillomavirus
- Hypoplastic Left Heart Syndrome
- Inflammatory Bowel Disease – Cadherin-Mediated Interventions
- Juvenile Idiopathic Arthritis (JIA) and Juvenile Dermatomyositis (JDM) – Microbiome
- Lupus - B-Cell Targets
- Metabolic Disorders – Newborn Screening
- Mitochondrial Disease
- Mosaic Mutations
- MRSA Infections
- Next-Generation Newborn Screening to Improve Treatment Efficacy
- Obesity
- Organ Development
- Retinal Disorders
- Scleroderma
- Sepsis
- Sleep Apnea
- Small Animal Imaging
- Stroke
- Wilson Disease and Other Lysosomal Storage Diseases--Newborn Screening
Educational Products and Digital Health
- Activity and Fitness
- Activity Trackers and Apps
- ADHD
- Adolescent-Focused Digital Health Interventions
- Digital Health
- Inflammatory Bowel Disease – Cadherin-Mediated Interventions
- Optimizing Child Development
- Pain
- Sleep Science – Researching Child, Adolescent and Family Sleep
Learn More
To learn more about partnering with Seattle Children’s Research Institute, or if you’re a Seattle Children’s researcher looking for industry partners. please contact:
Dr. Elizabeth Aylward
Director, Office of Science–Industry Partnerships
Email
206-844-1065